News from quest pharmatech inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 04, 2009, 12:36 ET

Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors

TSX Venture: QPT EDMONTON, March 4 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company") a pharmaceutical...

Feb 02, 2009, 07:00 ET

Quest PharmaTech Announces a Review of Strategic Alternatives to Enhance Shareholder Value

TSX Venture: QPT EDMONTON, Feb. 2 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical...

Jun 25, 2008, 01:00 ET

Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal

EDMONTON, June 25 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company"), today announced interim results from...

Jun 02, 2008, 01:00 ET

Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis

EDMONTON, June 2 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company"), today announced that its 12-patient,...

Apr 22, 2008, 01:00 ET

Quest PharmaTech Receives Support from National Research Council's Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer

EDMONTON, April 22 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") is pleased to announce that it will receive generous...

Jan 28, 2008, 00:00 ET

Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer

EDMONTON, Jan. 28 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") today announced that it has signed a collaborative...

Dec 17, 2007, 00:00 ET

Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology

EDMONTON, Dec. 17 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX Venture Exchange: QPT) today announced that it has signed an agreement with...

May 14, 2007, 01:00 ET

Quest PharmaTech and Paramount BioSciences Sign Exclusive Multinational License Agreement to Develop and Commercialize SonoLight Technology for Dermatology Applications

EDMONTON, AB and SAN DIEGO, CA, May 14 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest") (TSX: QPT) announced today that Paramount...

May 02, 2007, 01:00 ET

Quest PharmaTech's Prostate Cancer Program Update

EDMONTON, May 2 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") Quest is pleased to provide an update on the...

Jan 09, 2007, 00:00 ET

Quest PharmaTech Initiates a Fifty Patient Pivotal Clinical Trial for Cosmetic Hair Removal Applications

EDMONTON, Jan. 9 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") is pleased to announce that it has received clearance...

Jun 20, 2006, 01:00 ET

Quest Pharmatech INC. announces positive Phase I clinical trial results for cosmetic hair removal application

EDMONTON, June 20 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or "the Company") is pleased to announce that the Phase I clinical...